Knott David M Jr Madrigal Pharmaceuticals, Inc. Transaction History

Knott David M Jr

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$171.37 - $283.23 $1.92 Million - $3.18 Million	-11,216 Reduced 75.78%	3,584 $957,000
Q4 2023 Feb 13, 2024	SELL	$120.4 - $237.13 $24,080 - $47,426	-200 Reduced 1.33%	14,800 $3.42 Million
Q3 2023 Nov 13, 2023	BUY	$146.04 - $225.78 $146,040 - $225,780	1,000 Added 7.14%	15,000 $2.19 Million
Q1 2023 May 11, 2023	BUY	$231.06 - $307.08 $1.39 Million - $1.84 Million	6,000 Added 75.0%	14,000 $3.39 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $408,730 - $2.08 Million	7,000 Added 700.0%	8,000 $2.32 Million
Q3 2022 Nov 10, 2022	BUY	$60.57 - $79.51 $60,570 - $79,510	1,000 New	1,000 $65,000

299

22M

757K

370K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.71B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.